Cohen Fred E bought Intellia Therapeutics ($NTLA) shares once on the open market in the last year, for a total of $1.4 million. His most recent purchase occurred on January 5, 2026. This ranks him 403rd among roughly 5,000 individual insiders by purchase value, below the average of $1.46 million across about 3.3 transactions per insider. He made no open market sales in the period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 5, 2026 | Intellia Therapeutics, Inc. | $NTLA | Cohen Fred E | Not found | P | Common Stock | 150000 | $9.35 | 207,453.0000 | 115,829,926 | 261.08% | 0.13% |
| June 13, 2025 | CareDx, Inc. | $CDNA | Cohen Fred E | Not found | A | Common Stock | 12103 | $0.00 | 155,265.0000 | 56,620,590 | 8.45% | 0.02% |
| June 11, 2025 | Intellia Therapeutics, Inc. | $NTLA | Cohen Fred E | Not found | A | Common Stock | 8000 | $0.00 | 57,453.0000 | 103,517,460 | 16.18% | 0.01% |
| June 11, 2025 | Intellia Therapeutics, Inc. | $NTLA | Cohen Fred E | Not found | A | Stock Option (right to buy) | 11450 | $0.00 | 11,450.0000 | 103,517,460 | 9999.99% | 0.01% |
| May 29, 2025 | Kyverna Therapeutics, Inc. | $KYTX | Cohen Fred E | Not found | A | Common Stock | 16634 | $0.00 | 4,540,558.0000 | 43,214,918 | 0.37% | 0.04% |
| May 29, 2025 | Kyverna Therapeutics, Inc. | $KYTX | Cohen Fred E | Not found | A | Stock Option (right to buy) | 65351 | $0.00 | 65,351.0000 | 43,214,918 | 9999.99% | 0.15% |
| Aug. 6, 2024 | UroGen Pharma Ltd. | $URGN | Cohen Fred E | Director | A | Stock Option (right ot buy) | 10000 | $0.00 | 10,000.0000 | 40,501,315 | 9999.99% | 0.02% |
| June 14, 2024 | CareDx, Inc. | $CDNA | Cohen Fred E | Not found | A | Stock Option (right to buy) | 16048 | $0.00 | 16,048.0000 | 53,764,705 | 9999.99% | 0.03% |
| June 14, 2024 | CareDx, Inc. | $CDNA | Cohen Fred E | Not found | A | Common Stock | 10570 | $0.00 | 143,162.0000 | 53,764,705 | 7.97% | 0.02% |
| June 14, 2024 | CareDx, Inc. | $CDNA | Cohen Fred E | Not found | A | Stock Option (right to buy) | 16048 | $0.00 | 16,048.0000 | 53,764,705 | 9999.99% | 0.03% |
| June 12, 2024 | Intellia Therapeutics, Inc. | $NTLA | Cohen Fred E | Not found | A | Common Stock | 7737 | $0.00 | 49,453.0000 | 0 | 18.55% | 0.00% |
| June 12, 2024 | Intellia Therapeutics, Inc. | $NTLA | Cohen Fred E | Not found | A | Stock Option (right to buy) | 11515 | $0.00 | 11,515.0000 | 0 | 9999.99% | 0.00% |
| May 23, 2024 | Progyny, Inc. | $PGNY | Cohen Fred E | Director | A | Common Stock | 6176 | $0.00 | 22,693.0000 | 96,348,522 | 37.39% | 0.01% |
| May 23, 2024 | Progyny, Inc. | $PGNY | Cohen Fred E | Director | A | Stock Option (Right to Buy) | 25070 | $0.00 | 25,070.0000 | 96,348,522 | 9999.99% | 0.03% |
| Feb. 12, 2024 | Kyverna Therapeutics, Inc. | $KYTX | Cohen Fred E | Not found | C | Series B Redeemable Convertible Preferred Stock | 7356162 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 12, 2024 | Kyverna Therapeutics, Inc. | $KYTX | Cohen Fred E | Not found | C | Series A-2 Redeemable Convertible Preferred Stock | 8830901 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 12, 2024 | Kyverna Therapeutics, Inc. | $KYTX | Cohen Fred E | Not found | C | Series A-1 Redeemable Convertible Preferred Stock | 4401771 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Feb. 12, 2024 | Kyverna Therapeutics, Inc. | $KYTX | Cohen Fred E | Not found | C | Common Stock | 4523924 | $0.00 | 4,523,924.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | CareDx, Inc. | $CDNA | Cohen Fred E | Director | A | Common Stock | 18844 | $0.00 | 132,592.0000 | 53,321,625 | 16.57% | 0.04% |
| June 16, 2023 | CareDx, Inc. | $CDNA | Cohen Fred E | Director | A | Common Stock | 29136 | $0.00 | 29,136.0000 | 53,321,625 | 9999.99% | 0.05% |
| June 14, 2023 | Intellia Therapeutics, Inc. | $NTLA | Cohen Fred E | Director | A | Common Stock | 4425 | $0.00 | 41,716.0000 | 0 | 11.87% | 0.00% |
| June 14, 2023 | Intellia Therapeutics, Inc. | $NTLA | Cohen Fred E | Director | A | Stock Option (right to buy) | 6473 | $0.00 | 6,473.0000 | 0 | 9999.99% | 0.00% |
| May 24, 2023 | Progyny, Inc. | $PGNY | Cohen Fred E | Director | A | Common Stock | 4385 | $0.00 | 16,517.0000 | 93,301,156 | 36.14% | 0.00% |
| May 24, 2023 | Progyny, Inc. | $PGNY | Cohen Fred E | Director | A | Stock Option (Right to Buy) | 18350 | $0.00 | 18,350.0000 | 93,301,156 | 9999.99% | 0.02% |
| Jan. 6, 2023 | CareDx, Inc. | $CDNA | Cohen Fred E | Director | A | Common Stock | 1062 | $0.00 | 113,748.0000 | 53,321,625 | 0.94% | 0.00% |